ACE-inhibitory activity and ACE-inhibiting peptides in different cheese varieties

Dairy Science and Technology

Volumn 90, Issue 1, 2010, Pages 47-73

  Sieber, Robert ^a   Bütikofer, Ueli ^a   Egger, Charlotte ^a   Portmann, Reto ^a   Walther, Barbara ^a   Wechsler, Daniel ^a  

^a AGROSCOPE LIEBEFELD POSIEUX RESEARCH STATION ALP   (Switzerland)

Author keywords

ACE inhibiting peptide; ACE inhibitory activity; Cheese; Cheese ripening; IPP; Tripeptide; VPP

Indexed keywords

EID: 77950661092     PISSN: 19585586     EISSN: 19585594     Source Type: Journal    
DOI: 10.1051/dst/2009049     Document Type: Review

References (141)

1. Addeo F.,ChianeseL., SacchiR.,Musso S.S., Ferranti P., Malorni A., Characterization of the oligopeptides of Parmigiano-Reggiano cheese soluble in 120 g trichloroacetic acid, J. Dairy Res. 61 (1994) 365-374.
2. Ai L.Z., Guo B.H., Zhang H., Wu Z.J., Chen W., Wang Y.Y., Tang J.A., Isolation and antihypertensive effect of exopolysaccharides from Lactobacillus casei LC2W, Milchwissenschaft-Milk Sci. Int. 63 (2008) 3-6. (Pubitemid 351183662)
3. Aihara K., Kajimoto O., Hirata H., Takahashi R., Nakamura Y., Effect of powdered fermentedmilk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension, J. Am. Coll. Nutr. 24 (2005) 257-265. (Pubitemid 41357814)
4. Apostolidis E., Kwon Y.I., Shetty K., Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension, Innovat. Food Sci. Emerg. Technol. 8 (2007) 46-54. (Pubitemid 46217979)
5. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., Bray G.A., Vogt T.M., Cutler J.A., Windhauser M.M., Lin P.H., Karanja N., A clinical trial of the effects of dietary patterns on blood pressure, N. Engl. J. Med. 336 (1997) 1117-1124. (Pubitemid 27374693)
6. Ashar M.N., Chand R., Antihypertensive peptides purified from milks fermented with Lactobacillus delbrueckii ssp. bulgaricus, Milchwissenschaft-Milk Sci. Int. 59 (2004) 14-17. (Pubitemid 38261065)
7. Bachmann H.P., Bütikofer U., Badertscher R., Dalla Torre M., Lavanchy P., Bühler-Moor U., Nick B., Jimeno J., Warmke R., Grosch W., Sieber R., Bosset J.O., Reifungsverlauf von in Folien verpacktem Emmentaler Käse mit und ohne Zusatz von Lactobacillus casei subsp. casei. I. Mikrobiologische, chemische, rheologische und sensorische Untersuchungen, Lebensm.-Wiss. Technol. 30 (1997) 417-428.
8. Bachmann H.P., Bütikofer U., Meyer J., Prediction of flavour and texture development in Swiss-type cheeses, Food Sci. Technol.-Lebensm.-Wiss. Technol. 32 (1999) 284-289.
9. Bachmann H.P., Bütikofer U., Sieber R., Über das Vorkommen von bioaktiven Peptiden in Käse, Mitt. Lebensmittelunters. Hyg. 94 (2003) 136-154.
10. Bernard B.K., Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-Lproline and L-isoleucyl-L-prolyl-L-proline): I. Executive summary, Int. J. Toxicol. 24 (2005) 1-3. (Pubitemid 41540962)
11. Bernard B.K., Nakamura Y., Aihara K., Mennear J.H., Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-Lproline and L-isoleucyl-L-prolyl-L-proline): IX. Evaluation of the mutagenic potential of synthesized L-valyl-L-prolyl-L-proline in the Salmonella-Escherichia coli/microsome, incorporation assay, Int. J. Toxicol. 24 (2005) 107-113. (Pubitemid 41540970)
12. Bernard B.K., Nakamura Y., Bando I., Mennear J.H., Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-Lproline and L-isoleucyl-L-prolyl-L-proline): II. Introduction, Int. J. Toxicol. 24 (2005) 5-11. (Pubitemid 41540963)
13. Boelsma E., Kloek J., Lactotripeptides and antihypertensive effects: a critical review, Br. J. Nutr. 101 (2009) 776-786.
14. Bütikofer U., Baumann E., Sieber R., Bosset J.O., Ripening of Emmental cheese wrapped in foil with and without addition of Lactobacillus casei subsp. casei. IV. HPLC separation of water soluble peptides, Food Sci. Technol.-Lebensm.-Wiss. Technol. 31 (1998) 297-301. (Pubitemid 128360752)
15. Bütikofer U., Meyer J., Sieber R., Walther B., Wechsler D., Occurrence of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in different cheese varieties of Swiss origin, J. Dairy Sci. 91 (2008) 29-38.
16. Bütikofer U., Meyer J., Sieber R., Wechsler D., Quantification of the angiotensin-converting enzmye-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheeses, Int. Dairy J. 17 (2007) 968-975. (Pubitemid 46551704)
17. Cadée J.A., Chang C.Y., Chen C.W., Huang C.N., Chen S.L., Wang C.K., Bovine casein hydrolysate (C12 peptide) reduces blood pressure in prehypertensive subjects, Am. J. Hypertens. 20 (2007) 1-5.
18. Cheung H.S., Cushman D.W., Inhibition of homogeneous angiotensin- converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca, Biochim. Biophys. Acta-Enzymol. 293 (1973) 451-463.
19. Christensen J.E.,Dudley E.G., Pederson J.A., Steele J.L., Peptidases and amino acid catabolism in lactic acid bacteria, Antonie van Leeuwenhoek, Int. J. Gen. Molec. Microbiol. 76 (1999) 217-246.
20. Curtis J.M., Dennis D., Waddell D.S., MacGillivray T., Ewart H.S., Determination of angiotensin-converting enzyme inhibitory peptide Leu-Lys-Pro-Asn-Met (LKPNM) in bonito muscle hydrolysates by LC-MS/MS, J. Agric. Food Chem. 50 (2002) 3919-3925. (Pubitemid 34734290)
21. Cushman D.W., Cheung H.S., Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung, Biochem. Pharmacol. 20 (1970) 1637-1648.
22. Dent M.P., O'Hagan S., Braun W.H., Schaetti P., Marburger A., Vogel O., A 90-day subchronic toxicity study and reproductive toxicity studies on ACE-inhibiting lactotripeptide, Food Chem. Toxicol. 45 (2007) 1468-1477. (Pubitemid 47031391)
23. Engberink M.F., Schouten E.G., Kok F.J., van Mierlo L.A.J., Brouwer I.A., Geleijnse J.M., Lactotripeptides show no effect on human blood pressure. Results from a double-blind randomized controlled trial, Hypertension 51 (2008) 399-405.
24. FitzGerald R.J., Murray B.A., Bioactive peptides and lactic fermentations, Int. J. Dairy Technol. 59 (2006) 118-125.
25. FitzGerald R.J., Murray B.A., Walsh D.J., Hypotensive peptides from milk proteins, J. Nutr. 134 (2004) 980S-988S.
26. Foltz M., Meynen E.E., Bianco V., van Platerink C., Koning T.M.M.G., Kloek J., Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation, J. Nutr. 137 (2007) 953-958. (Pubitemid 46596893)
27. Fuglsang A., Nilsson D., Nyborg N.C.B., Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats, Appl. Environ. Microbiol. 68 (2002) 3566-3569. (Pubitemid 34734060)
28. Gagnaire V., Mollé D., Herrouin M., Léonil J., Peptides identified during Emmental cheese ripening: origin and proteolytic systems involved, J. Agric. Food Chem. 49 (2001) 4402-4413. (Pubitemid 32896445)
29. Gavras H., Brunner H.R., Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure, Hypertension 37 (2001) 342-345. (Pubitemid 32198990)
30. GobbettiM., FerrantiP.,SmacchiE.,Goffredi F., Addeo F., Production of angiotensin-Iconverting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4, Appl. Environ. Microbiol. 66 (2000) 3898-3904.
31. Gómez-Ruiz J.Á., Ramos M., Recio I., Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures, Int. Dairy J. 12 (2002) 697-706.
32. Gómez-Ruiz J.Á., Ramos M., Recio I., Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion, Int. Dairy J. 14 (2004) 1075-1080. (Pubitemid 39239307)
33. Gómez-Ruiz J.Á., Ramos M., Recio I., Identification and formation of angiotensinconverting enzyme-inhibitory peptides in Manchego cheese by high-performance liquid chromatography-tandem mass spectrometry, J. Chromatogr. A 1054 (2004) 269-277. (Pubitemid 39445829)
34. Gómez-Ruiz J.Á., Taborda G., Amigo L., Ramos M., Molina E., Sensory and mass spectrometric analysis of the peptidic fraction lower than one thousand daltons in Manchego cheese, J. Dairy Sci. 90 (2007) 4966-4973. (Pubitemid 351455383)
35. Gómez-Ruiz J.Á., Taborda G., Amigo L., Recio I., Ramos M., Identification of ACEinhibitory peptides in different Spanish cheeses by tandem mass spectrometry, Eur. Food Res. Technol. 223 (2006) 595-601. (Pubitemid 44199985)
36. Haque E., Chand R., Antihypertensive and antimicrobial bioactive peptides from milk proteins, Eur. Food Res. Technol. 227 (2008) 7-15. (Pubitemid 351491069)
37. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., Takano T., A placebocontrolled study of the effect of sour milk on blood pressure in hypertensive subjects, Am. J. Clin. Nutr. 64 (1996) 767-771. (Pubitemid 26398281)
38. Hernández-Ledesma B., Amigo L., Ramos M., Recio I., Angiotensin converting enzyme inhibitory activity in commercial fermented products, Formation of peptides under simulated gastrointestinal digestion, J. Agric. Food Chem. 52 (2004) 1504-1510.
39. Inoue K., Shirai T., Ochiai H., Kasao M., Hayakawa K., Kimura M., Sansawa H., Blood-pressure-lowering effect of a novel fermented milk containing β-aminobutyric acid (GABA) in mild hypertensives, Eur. J. Clin. Nutr. 57 (2003) 490-495. (Pubitemid 36395684)
40. Jang A., Lee M., Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates, Meat Sci. 69 (2005) 653-661. (Pubitemid 40119920)
41. Jauhiainen T., Blood pressure lowering effects of Lactobacillus helveticus fermented milk containing bioactive peptides Ile-Pro-Pro and Val-Pro-Pro: mechanistic, kinetic and clinical studies, Diss. University Helsinki, 2007, pp. 1-100.
42. Jauhiainen T., Vapaatalo H., Poussa T., Kyrönpalo S., Rasmussen M., Korpela R., Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement, Am. J. Hypertens. 18 (2005) 1600-1605. (Pubitemid 41814682)
43. Jauhiainen T., Wuolle K., Vapaatalo H., Kerojoki O., Nurmela K., Lowrie C., Korpela R., Oral absorption, tissue distribution and excretion of a radiolabelled analog of a milk-derived antihypertensive peptide, Ile-Pro-Pro, in rats, Int. Dairy J. 17 (2007) 1216-1223. (Pubitemid 47095279)
44. Kajimoto O., Aihara K., Hirata H., Takahashi R., Nakamura Y., Safety evaluation of excessive intake of the tablet containing "Lactotripeptides (VPP, IPP)" on healthy volunteers, J. Nutr. Food 4 (2001) 37-46.
45. Kamath V., Niketh S., Chandrashekar A., Rajini P.S., Chymotryptic hydrolysates of α-kafirin, the storage protein of sorghum (Sorghum bicolor) exhibited angiotensin converting enzyme inhibitory activity, Food Chem. 100 (2007) 306-311. (Pubitemid 43914193)
46. Katayama K., Anggraeni H.E., Mori T., Ahhmed A.M., Kawahara S., Sugiyama M., Nakayama T., Maruyama M., Muguruma M., Porcine skeletal muscle troponin is a good source of peptides with angiotensin-I converting enzyme inhibitory activity and antihypertensive effects in spontaneously hypertensive rats, J. Agric. Food Chem. 56 (2008) 355-360. (Pubitemid 351212557)
47. Katayama K., Jamhari, Mori T., Kawahara S., Miake K., Kodama Y., Sugiyama M., Kawamura Y., Nakayama T., Maruyama M., Muguruma M., Angiotensin-I converting enzyme inhibitory peptide derived from porcine skeletal muscle myosin and its antihypertensive activity in spontaneously hypertensive rats, J. Food Sci. 72 (2007) S702-S706. (Pubitemid 350150727)
48. Kenny O., FitzGerald R.J., O'Cuinn G., Beresford T., Jordan K., Growth phase and growth medium effects on the peptidase activities of Lactobacillus helveticus, Int. Dairy J. 13 (2003) 509-516. (Pubitemid 36821068)
49. Kilpi E.E.R., Kahala M.M., Steele J.L., Pihlanto A.M., Joutsjoki V.V., Angiotensin I-converting enzyme inhibitory activity in milk fermented by wild-type and peptidasedeletion derivatives of Lactobacillus helveticus CNRZ32, Int. Dairy J. 17 (2007) 976-984.
50. Korhonen H., Milk-derived bioactive peptides: From science to applications, J. Funct. Foods 1 (2009) 177-187.
51. Kurosaki T., Maeno M., Mennear J.H., Bernard B.K., Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): VI. Effects of Lactobacillus helveticus-fermented milk powder on fertility and reproductive performance of rats, Int. J. Toxicol. 24 (2005) 61-89. (Pubitemid 41540967)
52. Leclerc P.L., Gauthier S.F., Bachelard H., Santure M., Roy D., Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus, Int. Dairy J. 12 (2002) 995-1004. (Pubitemid 36189298)
53. Li G.H., Le G.W., Shi Y.H., Shrestha S., Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects, Nutr. Res. 24 (2004) 469-486. (Pubitemid 38968489)
54. Lo W.M.Y., Li-Chan E.C.Y., Angiotensin I converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein, J. Agric. Food Chem. 53 (2005) 3369-3376. (Pubitemid 40758169)
55. Maeno M., Mizuno S., Mennear J.H., Bernard B.K., Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-Lproline and L-isoleucyl-L-prolyl-L-proline): VIII. Assessment of cytotoxicity and clastogenicity of tripeptides-containing casein hydrolysate and Lactobacillus helveticus-fermented milk powders in Chinese hamster lung cells, Int. J. Toxicol. 24 (2005) 97-105.
56. Maeno M., Nakamura Y., Mennear J.H., Bernard B.K., Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-Lproline and L-isoleucyl-L-prolyl-L-proline): III. Single-and/or repeated-dose toxicity of tripeptides-containing Lactobacillus helveticus-fermented milk powder and casein hydrolysate in rats, Int. J. Toxicol. 24 (2005) 13-23. (Pubitemid 41540964)
57. Maeno M., Yamamoto N., Takano T., Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790, J. Dairy Sci. 79 (1996) 1316-1321.
58. Mäkinen S., Kelloniemi J., Pihlanto A., Mäkinen K., Korhonen H., Hopia A., Valkonen J.P.T., Inhibition of angiotensin converting enzyme I caused by autolysis of potato proteins by enzymatic activities confined to different parts of the potato tuber, J. Agric. Food Chem. 56 (2008) 9875-9883.
59. Masuda O., Nakamura Y., Takano T., Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats, J. Nutr. 126 (1996) 3063-3068.
60. Matsufuji H., Matsui T., Seki E., Osajima K., Nakashima M., Osajima Y., Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle, Biosci. Biotechnol. Biochem. 58 (1994) 2244-2245.
61. Matsui T., Matsufuji H., Seki E., Osajima K., Nakashima M., Osajima Y., Inhibition of angiotensin I-converting enzyme by Bacillus licheniformis alkaline protease hydrolyzates derived from sardine muscle, Biosci. Biotechnol. Biochem. 57 (1993) 922-925.
62. Matsui T., Yukiyoshi A., Doi S., Sugimoto H., Yamada H., Matsumoto K., Gastrointestinal enzyme production of bioactive peptides from royal jelly protein, their antihypertensive ability in SHR, J. Nutr. Biochem. 13 (2002) 80-86.
63. McCarron D.A., Reusser M.E., Finding consensus in the dietary calcium-blood pressure debate, J. Am. Coll. Nutr. 18 (1999) 398S-405S.
64. Meisel H., Goepfert A., Günther S., ACEinhibitory activities in milk products, Milchwissenschaft-Milk Sci. Int. 52 (1997) 307-311.
65. Meisel H., Walsh D.J., Murray B., Fitz-Gerald R.J., ACE inhibiting peptides, in: Mine Y., Shahidi S. (Eds.), Nutraceutical Proteins and Peptides in Health and Disease, CRC Press, New York, USA, 2006, pp. 269-315.
66. Meyer J., Bütikofer U., Walther B., Wechsler D., Sieber R., Changes in angiotensin-converting enzyme inhibition and concentrations of the tripeptides Val-Pro-Pro and Ile-Pro-Pro during ripening of different Swiss cheese varieties, J. Dairy Sci. 92 (2009) 826-836.
67. Miguel M., Aleixandre A., Antihypertensive peptides derived from egg proteins, J. Nutr. 136 (2006) 1457-1460.
68. Miguel M., Manso M., Aleixandre A., Alonso M.J., Salaices M., López-Fandiño R., Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white, J. Agric. Food Chem. 55 (2007) 10615-10621.
69. Minervini F., Algaron F., Rizzello C.G., Fox P.F., Monnet V., Gobbetti A., Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species, Appl. Environ. Microbiol. 69 (2003) 5297-5305.
70. Mito K., Fujii M., Kuwahara M., Matsumura N., Shimizu T., Sugano S., Karaki H., Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides derived from hemoglobin, Eur. J. Pharmacol. 304 (1996) 93-98. (Pubitemid 26342677)
71. Miyoshi S., Kaneko T., Yoshizawa Y., Fukui F., Tanaka H., Maruyama S., Hypotensive activity of enzymatic α-zein hydrolysate, Agric. Biol. Chem. 55 (1991) 1407-1408.
72. Mizuno S., Matsuura K., Gotou T., Nishimura S., Kajimoto O., Yabune M., Kajimoto Y., Yamamoto N., Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension, Br. J. Nutr. 94 (2005) 84-91. (Pubitemid 41357814)
73. Mizuno S., Mennear J.H., Matsuura K., Bernard B.K., Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-Lproline, L-isoleucyl-L-prolyl-L-proline): V. A 13-week toxicity study of tripeptidescontaining casein hydrolysate in male and female rats, Int. J. Toxicol. 24 (2005) 41-59. (Pubitemid 41540966)
74. Mizushima S., Ohshige K., Watanabe J., Kimura M., Kadowaki T., Nakamura Y., Tochikubo O., Ueshima H., Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men, Am. J. Hypertens. 17 (2004) 701-706. (Pubitemid 39091551)
75. Möller N.P., Scholz-Ahrens K.E., Roos N., Schrezenmeir J., Bioactive peptides and proteins from foods: indication for health effects, Eur. J. Nutr. 47 (2008) 171-182.
76. Muguerza B., Ramos M., Sanchez E., Manso M.A., Miguel M., Aleixandre A., Delgado M.A., Recio I., Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk, Int. Dairy J. 16 (2006) 61-69. (Pubitemid 41531152)
77. Nakamura Y., Bando I., Mennear J.H., Bernard B.K., Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-Lproline and L-isoleucyl-L-prolyl-L-proline): IV. Assessment of the repeated-dose toxicological potential of synthesized L-valyl-L-prolyl-L-proline in male and female rats and dogs, Int. J. Toxicol. 24 (2005) 25-39. (Pubitemid 41540965)
78. Nakamura Y., Takano T., Angiotensin converting enzyme inhibitor and method for preparing same, US Patent 5449661, 1995.
79. Nakamura Y., Yamamoto N., Sakai K., Okubo A., Yamazaki S., Takano T., Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk, J. Dairy Sci. 78 (1995) 777-783.
80. Nakamura Y., Yamamoto N., Sakai K., Takano T., Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme, J. Dairy Sci. 78 (1995) 1253-1257.
81. Nakano D., Ogura K., Miyakoshi M., Ishii F., Kawanishi H., Kurumazuka D., Kwak C.J., Ikemura K., Takaoka M., Moriguchi S., Iino T., Kusumoto A., Asami S., Shibata H., Kiso Y., Matsumura Y., Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats, Biosci. Biotechnol. Biochem. 70 (2006) 1118-1126. (Pubitemid 43765241)
82. Nielsen M.S., Martinussen T., Flambard B., Sørensen K.I., Otte J., Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: effect of bacterial strain, fermentation pH, and storage time, Int. Dairy J. 19 (2009) 155-165.
83. Nussberger J., Blutdrucksenkende Tripeptide aus der Milch, Ther. Umsch. 64 (2007) 177-179. (Pubitemid 46423203)
84. Ohsawa K., Satsu H., Ohki K., Enjoh M., Takano T., Shimizu M., Producibility and digestibility of antihypertensive β-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion, J. Agric. Food Chem. 56 (2008) 854-858. (Pubitemid 351300255)
85. Okamoto A., Hanagata H., Matsumoto E., Kawamura Y., Koizumi Y., Yanagida F., Angiotensin-converting enzyme inhibitory activities of various fermented foods, Biosci. Biotechnol. Biochem. 59 (1995) 1147-1149.
86. Ong L., Henriksson A., Shah N.P., Angiotensin converting enzyme-inhibitory activity in Cheddar cheeses made with the addition of probiotic Lactobacillus casei sp., Lait 87 (2007) 149-165. (Pubitemid 47137468)
87. Ong L., Shah N.P., Influence of probiotic Lactobacillus acidophilus and L. helveticus on proteolysis, organic acid profiles, and ACE-inhibitory activity of Cheddar cheeses ripened at 4, 8, and 12 °C, J. Food Sci. 73 (2008) M111-M120. (Pubitemid 351489969)
88. Ong L., Shah N.P., Release and identification of angiotensin-converting enzymeinhibitory peptides as influenced by ripening temperatures and probiotic adjuncts in Cheddar cheeses, LWT - Food Sci. Technol. 41 (2008) 1555-1566.
89. Pan D., Luo Y., Tanokura M., Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004, Food Chem. 91 (2005) 123-129. (Pubitemid 39572541)
90. Parrot S., Degraeve P., Curia C., Martial-Gros A., In vitro study on digestion of peptides in Emmental cheese: analytical evaluation and influence on angiotensin I converting enzyme inhibitory peptides, Nahrung-Food 47 (2003) 87-94. (Pubitemid 37373985)
91. Pihlanto A., Akkanen S., Korhonen H.J., ACE-inhibitory and antioxidant properties of potato (Solanum tuberosum), Food Chem. 109 (2008) 104-112.
92. Ponstein-Simarro DoortenA.Y., vdWiel J.A.G., Jonker D., Safety evaluation of an IPP tripeptide-containing milk protein hydrolysate, Food Chem. Toxicol. 47 (2009) 55-61.
93. Pozo-Bayón M.A., Alcaide J.M., Polo M.C., Pueyo E., Angiotensin I-converting enzyme inhibitory compounds in white and red wines, Food Chem. 100 (2007) 43-47. (Pubitemid 43914162)
94. Pripp A.H., Effect of peptides derived from food proteins on blood pressure: a metaanalysis of randomized controlled trials, Food Nutr. Res. 52 (2008) DOI: 10.3402/fnr. v52i0.1641. http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC2596738/pdf/FNR-52-1641.pdf.
95. Pripp A.H., Sørensen R., Stepaniak L., Sørhaug T., Relationship between proteolysis and angiotensin-I-converting enzyme inhibition in different cheeses, LWT - Food Sci. Technol. 39 (2006) 677-683. (Pubitemid 43340493)
96. Prospective Studies Collaboration, Agespecific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet 360 (2002) 1903-1913.
97. Quirós A., Chichón R., Recio I., López-Fandiño R., The use of high hydrostatic pressure to promote the proteolysis and release of bioactive peptides fromovalbumin, Food Chem. 104 (2007) 1734-1739. (Pubitemid 46783247)
98. Quist E.E., Phillips R.D., Saalia F.K., Angiotensin converting enzyme inhibitory activity of proteolytic digests of peanut (Arachis hypogaea L.) flour, LWT - Food Sci. Technol. 42 (2009) 694-699.
99. Rank T.C., Grappin R., Olson N.F., Secondary proteolysis of cheese during ripening. A review, J. Dairy Sci. 68 (1985) 801-805.
100. Robert M.C., Razaname A., Mutter M., Juillerat M.A., Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765, J. Agric. Food Chem. 52 (2004) 6923-6931.
101. Rufián-Henares J.A., Morales F.J., Angiotensin-I converting enzyme inhibitory activity of coffee melanoidins, J. Agric. Food Chem. 55 (2007) 1480-1485.
102. Ryhänen E.L., Pihlanto-Leppälä A., Pahkala E., A new type of ripened, lowfat cheese with bioactive properties, Int. Dairy J. 11 (2001) 441-447. (Pubitemid 32752183)
103. Saiga A., Iwai K., Hayakawa T., Takahata Y., Kitamura S., Nishimura T., Morimatsu F., Angiotensin I-converting enzyme-inhibitory peptides obtained from chicken collagen hydrolysate, J. Agric. Food Chem. 56 (2008) 9586-9591.
104. Saiga A., Okumura T., Makihara T., Katsuda S.I., Morimatsu F., Nishimura T., Action mechanism of an angiotensin I-converting enzyme inhibitory peptide derived from chicken breast muscle, J. Agric. Food Chem. 54 (2006) 942-945. (Pubitemid 43274135)
105. Saito T., Nakamura T., Kitazawa H., Kawai Y., Itoh T., Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese, J. Dairy Sci. 83 (2000) 1434-1440.
106. Sano J., Ohki K., Higuchi T., Aihara K., Mizuno S., Kajimoto O., Nakagawa S., Kajimoto Y., Nakamura Y., Safety evaluation of excessive intake of drink containing "lactotripeptides (VPP, IPP)" in subjects with normal blood pressure to mild hypertension, J. Nutr. Food 7 (2005) 17-30.
107. Savijoki K., Palva A., Purification and molecular characterization of a tripeptidase (PepT) from Lactobacillus helveticus, Appl. Environ. Microbiol. 66 (2000) 794-800. (Pubitemid 30082776)
108. Schär H., Glättli H., Moor U., Nick B., Sieber R., Steiger G., Untersuchungen über den Reifungsverlauf von qualitativ gutem Walliser Raclettekäse, Schweiz. Milchwirt. Forsch. 21 (1992) 52-57.
109. Seppo L., Jauhiainen T., Poussa T., Korpela R., A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects, Am. J. Clin. Nutr. 77 (2003) 326-330. (Pubitemid 36133373)
110. Seppo L., Kerojoki O., Suomalainen T., Korpela R., The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension - a pilot study on humans, Milchwissenschaft-Milk Sci. Int. 57 (2002) 124-127. (Pubitemid 34881652)
111. Shalaby S.M., Zakora M., Otte J., Performance of two commonly used angiotensinconverting enzyme inhibition assays using FA-PGG and HHL as substrates, J. Dairy Res. 73 (2006) 178-186.
112. Sheih I.-C., Fang T.J., Wu T.-K., Isolation and characterisation of a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from the algae protein waste, Food Chem. 115 (2009) 279-284.
113. Shuangquan, Tsuda H., Myamoto T., Angiotensin I-converting enzyme inhibitory peptides in skim milk fermented with Lactobacillus helveticus 130B4 from camel milk in Inner Mongolia, China, J. Sci. Food Agric. 88 (2008) 2688-2692.
114. Sieber R., Käse - ein wertvolles Lebensmittel in der menschlichen Ernährung, Mitt. Lebensm. Hyg. 96 (2005) 141-170.
115. Silva S.V., Pihlanto A., Malcata F.X., Bioactive peptides in ovine and caprine cheeselike systems prepared with proteases from Cynara cardunculus, J. Dairy Sci. 89 (2006) 3336-3344. (Pubitemid 44305976)
116. Sipola M., Finckenberg P., Korpela R., Vapaatalo H., Nurminen M.L., Effect of long-term intake of milk products on blood pressure in hypertensive rats, J. Dairy Res. 69 (2002) 103-111. (Pubitemid 34544013)
117. Sipola M., Finckenberg P., Santisteban J., Korpela R., Vapaatalo H., Nurminen M.L., Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats, J. Physiol. Pharmacol. 52 (2001) 745-754. (Pubitemid 34042359)
118. Smacchi E., Gobbetti M., Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme, Enzyme Microb. Technol. 22 (1998) 687-694. (Pubitemid 28312624)
119. Sollberger H., Glättli H., Nick B., Rüegg M., Sieber R., Steiger G., Untersuchungen über den Reifungsverlauf guter Sbrinz-Käse, Schweiz. Milchwirt. Forschung 20 (1991) 63-69.
120. Steffen C., Rentsch F., Nick B., Steiger G., Sieber R., Glättli H., Eberhard P., Reifungsverlauf in qualitativ gutemGruyère, Landwirt. Schweiz 5 (1992) 209-215.
121. Steffen C., Schär H., Eberhard P., Glättli H., Nick B., Rentsch F., Steiger G., Sieber R., Untersuchungen über den Reifungsverlauf von qualitativ gutem Käse: Appenzeller, Schweiz. Milchwirt. Forsch. 21 (1993) 39-45.
122. Steffen C., Schär H., Eberhard P., Glättli H., Nick B., Rentsch F., Steiger G., Sieber R., Untersuchungen über den Reifungsverlauf von qualitativ gutem Käse: Tilsiter aus Rohmilch, Schweiz. Milchwirt. Forsch. 21 (1993) 46-51.
123. Stepaniak L., Jedrychowski L., Wróblewska B., Sørhaug T., Immunoreactivity and inhibition of angiotensin-I converting enzyme and lactococcal oligopeptidase by peptides fromcheese, Ital. J. Food Sci. 13 (2001) 373-381. (Pubitemid 33590281)
124. Taubert D., Roesen R., Schömig E., Effect of cocoa and tea intake on blood pressure. A meta-analysis, Arch. Int. Med. 167 (2007) 626-634. (Pubitemid 46603652)
125. Tonouchi H., Suzuki M., Uchida M., Oda M., Antihypertensive effect of an angiotensin converting enzyme inhibitory peptide from enzyme modified cheese, J. Dairy Res. 75 (2008) 284-290.
126. Tossavainen O., Suomalainen T., Sahlstein J., Mäyrä- Mäkinen A., Verfahren zur Herstellung eines Produktes, welches gegen Bluthochdruck gerichtete Tripeptide enthält, Dt. Patent DE 600 10 742 T2 (2005).
127. Townsend R.R., McFadden C.B., Ford V., Cadée J.A., A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension, Am. J. Hypertens. 17 (2004) 1056-1058. (Pubitemid 39469330)
128. Tuomilehto J., Lindström J., Hyyrynen J., Korpela R., Karhunen M.L., Mikkola L., Jauhiainen T., Seppo L., Nissinen A., Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension, J. Hum. Hypertens. 18 (2004) 795-802. (Pubitemid 39530092)
129. van der Pijl P.C.,KiesA.K.,TenHaveG.A.M., Duchateau G.S.M.J.E., Deutz N.E.P., Pharmacokinetics of proline-rich tripeptides in the pig, Peptides 29 (2008) 2196-2202.
130. van der Zander K., Bots M.L., Bak A.A.A., Koning M.M.G., de Leeuw P.W., Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects, Am. J. Clin. Nutr. 88 (2008) 1697-1702.
131. van Mierlo L.A.J., Koning M.M.G., van der Zander K., Draijer R., Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies, Am. J. Clin. Nutr. 89 (2009) 617-623.
132. van Platerink C.J., Janssen H.G., Horsten R., Haverkamp J., Quantification of ACE inhibiting peptides in human plasma using high performance liquid chromatographymass spectrometry, J. Chromatogr. B 830 (2006) 151-157. (Pubitemid 41831401)
133. Vermeirssen V., Van Camp J., Verstraete W., Optimisation and validation of an angiotensin-converting enzyme inhibition assay for the screening of bioactive peptides, J. Biochem. Biophys. Methods 51 (2002) 75-87. (Pubitemid 34203814)
134. Wang J., Hu J., Cui J., Bai X., Du Y., Miyaguchi Y., Lin B., Purification and identification of a ACE inhibitory peptide from oyster proteins hydrolysate and the antihypertensive effect of hydrolysate in spontaneously hypertensive rats, Food Chem. 111 (2008) 302-308.
135. Webb A.J., Patel N., Loukogeorgakis S., Okorie M., Aboud Z., Misra S., Rashid R., Miall P., Deanfield J., Benjamin N., MacAllister R., Hobbs A.J., Ahluwalia A., Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite, Hypertension 51 (2008) 784-790. (Pubitemid 351301536)
136. XuJ.Y.,Qin L.Q.,Wang P.Y., LiW.,Chang C., Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials, Nutrition 24 (2008) 933-940.
137. Yamamoto N., Akino A., Takano T., Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790, J. Dairy Sci. 77 (1994) 917-922.
138. Yamamoto N., Akino A., Takano T., Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats, Biosci. Biotechnol. Biochem. 58 (1994) 776-778.
139. Yamamoto N., Maeno M., Takano T., Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4, J. Dairy Sci. 82 (1999) 1388-1393. (Pubitemid 129632528)
140. Yang Y., Tao G., Liu P., Liu J., Peptide with angiotensin I-converting enzyme inhibitory activity from hydrolyzed corn gluten meal, J. Agric. Food Chem. 55 (2007) 7891-7895. (Pubitemid 47522204)
141. Yano S., Suzuki K., Funatsu G., Isolation from β-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity, Biosci. Biotechnol. Biochem. 60 (1996) 661-663. (Pubitemid 126477706)